{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:43:46Z","timestamp":1790401426676,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C2768"],"award-info":[{"award-number":["HI14C2768"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00259-018-4125-x","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T12:08:11Z","timestamp":1534248491000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias"],"prefix":"10.1007","volume":"46","author":[{"given":"Hye Joo","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsu S.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Hoon","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"4125_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci. 2007;8:663\u201372. \n                    https:\/\/doi.org\/10.1038\/nrn2194\n                    \n                  .","journal-title":"Nat Rev Neurosci"},{"key":"4125_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546\u201354.","journal-title":"Neurology"},{"key":"4125_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1468-1331.2001.00179.x","volume":"8","author":"S Siri","year":"2001","unstructured":"Siri S, Benaglio I, Frigerio A, Binetti G, Cappa SF. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer\u2019s disease. Eur J Neurol. 2001;8:125\u201332.","journal-title":"Eur J Neurol"},{"key":"4125_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer disease centers, 2005-2010. J Neuropathol Exp Neurol. 2012;71:266\u201373. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31824b211b\n                    \n                  .","journal-title":"J Neuropathol Exp Neurol"},{"key":"4125_CR5","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awv191","volume":"138","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, et al. The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features. Brain. 2015;138:2732\u201349. \n                    https:\/\/doi.org\/10.1093\/brain\/awv191\n                    \n                  .","journal-title":"Brain"},{"key":"4125_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","volume":"77","author":"GD Rabinovici","year":"2011","unstructured":"Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 2011;77:2034\u201342. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31823b9c5e\n                    \n                  .","journal-title":"Neurology"},{"key":"4125_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/archneur.64.2.246","volume":"64","author":"B Borroni","year":"2007","unstructured":"Borroni B, Brambati SM, Agosti C, Gipponi S, Bellelli G, Gasparotti R, et al. Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol. 2007;64:246\u201351. \n                    https:\/\/doi.org\/10.1001\/archneur.64.2.246\n                    \n                  .","journal-title":"Arch Neurol"},{"key":"4125_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000457127","volume":"17","author":"R Taipa","year":"2017","unstructured":"Taipa R, Brochado P, Robinson A, Reis I, Costa P, Mann DM, et al. Patterns of microglial cell activation in Alzheimer disease and frontotemporal lobar degeneration. Neurodegener Dis. 2017;17:145\u201354. \n                    https:\/\/doi.org\/10.1159\/000457127\n                    \n                  .","journal-title":"Neurodegener Dis"},{"key":"4125_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14:463\u201377. \n                    https:\/\/doi.org\/10.1038\/nri3705\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"key":"4125_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Holtzman DM. Glial contributions to neurodegeneration in tauopathies. Mol Neurodegener. 2017;12:50. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0192-x\n                    \n                  .","journal-title":"Mol Neurodegener"},{"key":"4125_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD, et al. Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias. Alzheimers Dement. 2016;12:1116\u201324. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.01.003\n                    \n                  .","journal-title":"Alzheimers Dement"},{"key":"4125_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.115.164848","volume":"57","author":"R Harada","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, et al. 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. J Nucl Med. 2016;57:208\u201314. \n                    https:\/\/doi.org\/10.2967\/jnumed.115.164848\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"4125_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","volume":"9","author":"KP Ng","year":"2017","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, et al. Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain. Alzheimers Res Ther. 2017;9:25. \n                    https:\/\/doi.org\/10.1186\/s13195-017-0253-y\n                    \n                  .","journal-title":"Alzheimers Res Ther"},{"key":"4125_CR14","doi-asserted-by":"publisher","unstructured":"Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, et al. Correlations of (18)F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer\u2019s disease. J Nucl Med. 2017. \n                    https:\/\/doi.org\/10.2967\/jnumed.117.197426\n                    \n                  .","DOI":"10.2967\/jnumed.117.197426"},{"key":"4125_CR15","volume-title":"Seoul Neuropsychological Screening Battery","author":"Y Kang","year":"2003","unstructured":"Kang Y, Na DL, Hahn S. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.; 2003."},{"key":"4125_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005\n                    \n                  .","journal-title":"Alzheimers Dement"},{"issue":"Suppl 1","key":"4125_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S1041610297004717","volume":"9","author":"RC Petersen","year":"1997","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl 1):65\u20139.","journal-title":"Int Psychogeriatr"},{"key":"4125_CR18","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/brain\/awn234","volume":"131","author":"DS Knopman","year":"2008","unstructured":"Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008;131:2957\u201368. \n                    https:\/\/doi.org\/10.1093\/brain\/awn234\n                    \n                  .","journal-title":"Brain"},{"key":"4125_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","volume":"38","author":"BA Thomas","year":"2011","unstructured":"Thomas BA, Erlandsson K, Modat M, Thurfjell L, Vandenberghe R, Ourselin S, et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38:1104\u201319. \n                    https:\/\/doi.org\/10.1007\/s00259-011-1745-9\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4125_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367. \n                    https:\/\/doi.org\/10.1093\/brain\/aww027\n                    \n                  .","journal-title":"Brain"},{"key":"4125_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/brain\/awg085","volume":"126","author":"E Schofield","year":"2003","unstructured":"Schofield E, Kersaitis C, Shepherd CE, Kril JJ, Halliday GM. Severity of gliosis in Pick\u2019s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain. 2003;126:827\u201340.","journal-title":"Brain"},{"key":"4125_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00401-005-1079-4","volume":"110","author":"J Shi","year":"2005","unstructured":"Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol. 2005;110:501\u201312. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1079-4\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"4125_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Mielke ML, Gomez-Isla T, Betensky RA, Growdon JH, Frosch MP, et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am J Pathol. 2011;179:1373\u201384. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.047\n                    \n                  .","journal-title":"Am J Pathol"},{"key":"4125_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-131481","volume":"39","author":"PH Lu","year":"2014","unstructured":"Lu PH, Lee GJ, Shapira J, Jimenez E, Mather MJ, Thompson PM, et al. Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer\u2019s disease. J Alzheimers Dis. 2014;39:261\u20139. \n                    https:\/\/doi.org\/10.3233\/JAD-131481\n                    \n                  .","journal-title":"J Alzheimers Dis"},{"key":"4125_CR25","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/brain\/awp071","volume":"132","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, Gorno-Tempini ML, et al. White matter damage in frontotemporal dementia and Alzheimer\u2019s disease measured by diffusion MRI. Brain. 2009;132:2579\u201392. \n                    https:\/\/doi.org\/10.1093\/brain\/awp071\n                    \n                  .","journal-title":"Brain"},{"key":"4125_CR26","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMcibr1202401","volume":"366","author":"J Hardy","year":"2012","unstructured":"Hardy J, Revesz T. The spread of neurodegenerative disease. N Engl J Med. 2012;366:2126\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJMcibr1202401\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"4125_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00415-011-6300-x","volume":"259","author":"MC Tartaglia","year":"2012","unstructured":"Tartaglia MC, Zhang Y, Racine C, Laluz V, Neuhaus J, Chao L, et al. Executive dysfunction in frontotemporal dementia is related to abnormalities in frontal white matter tracts. J Neurol. 2012;259:1071\u201380. \n                    https:\/\/doi.org\/10.1007\/s00415-011-6300-x\n                    \n                  .","journal-title":"J Neurol"},{"key":"4125_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.neuroimage.2010.01.041","volume":"50","author":"BB Avants","year":"2010","unstructured":"Avants BB, Cook PA, Ungar L, Gee JC, Grossman M. Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. NeuroImage. 2010;50:1004\u201316. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2010.01.041\n                    \n                  .","journal-title":"NeuroImage"},{"key":"4125_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0197-4580(97)00037-7","volume":"18","author":"JS Fowler","year":"1997","unstructured":"Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, et al. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging. 1997;18:431\u20135.","journal-title":"Neurobiol Aging"},{"key":"4125_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/brain\/awp248","volume":"133","author":"JR Hodges","year":"2010","unstructured":"Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain. 2010;133:300\u20136. \n                    https:\/\/doi.org\/10.1093\/brain\/awp248\n                    \n                  .","journal-title":"Brain"},{"key":"4125_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.24885","volume":"81","author":"EG Spinelli","year":"2017","unstructured":"Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F, et al. Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol. 2017;81:430\u201343. \n                    https:\/\/doi.org\/10.1002\/ana.24885\n                    \n                  .","journal-title":"Ann Neurol"},{"key":"4125_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137\u201353. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0839-6\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"4125_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","volume":"127","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol. 2014;127:423\u201339. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1238-y\n                    \n                  .","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4125_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/wad.0000000000000216","volume":"32","author":"H Lee","year":"2018","unstructured":"Lee H, Seo S, Lee SY, Jeong HJ, Woo SH, Lee KM, et al. [18F]-THK5351 PET imaging in patients with semantic variant primary progressive aphasia. Alzheimer Dis Assoc Disord. 2018;32(1):62\u20139. \n                    https:\/\/doi.org\/10.1097\/wad.0000000000000216\n                    \n                  .","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4125_CR35","doi-asserted-by":"publisher","unstructured":"Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer TD, et al. [(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. J Neurol Neurosurg Psychiatry. 2017. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-316402\n                    \n                  .","DOI":"10.1136\/jnnp-2017-316402"},{"key":"4125_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5\u201322. \n                    https:\/\/doi.org\/10.1007\/s00401-007-0237-2\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"4125_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.nicl.2015.06.005","volume":"8","author":"LE Downey","year":"2015","unstructured":"Downey LE, Mahoney CJ, Buckley AH, Golden HL, Henley SM, Schmitz N, et al. White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration. Neuroimage Clin. 2015;8:640\u201351. \n                    https:\/\/doi.org\/10.1016\/j.nicl.2015.06.005\n                    \n                  .","journal-title":"Neuroimage Clin"},{"key":"4125_CR38","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/brain\/awq075","volume":"133","author":"J Zhou","year":"2010","unstructured":"Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer\u2019s disease. Brain. 2010;133:1352\u201367.","journal-title":"Brain"},{"key":"4125_CR39","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1523\/JNEUROSCI.5587-06.2007","volume":"27","author":"WW Seeley","year":"2007","unstructured":"Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349\u201356. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5587-06.2007\n                    \n                  .","journal-title":"J Neurosci"},{"issue":"8","key":"4125_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/wnl.0000000000003636","volume":"88","author":"S Spina","year":"2017","unstructured":"Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O\u2019Neil JP, et al. Frontotemporal dementia with the V337M MAPT mutation: tau-PET and pathology correlations. Neurology. 2017;88(8):758\u201366. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000003636\n                    \n                  .","journal-title":"Neurology"},{"issue":"3","key":"4125_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00259-017-3876-0","volume":"45","author":"YK Jang","year":"2018","unstructured":"Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, et al. Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer\u2019s disease and frontotemporal dementia. Eur J Nucl Med Mol Imaging. 2018;45(3):432\u201342. \n                    https:\/\/doi.org\/10.1007\/s00259-017-3876-0\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4125-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T15:42:06Z","timestamp":1568907726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4125-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4125"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4125-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"25 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}